Istanbul University-Cerrahpaşa is a public university which was formed in Istanbul on 18 May 2018. It takes its name from Cerrah Mehmed Pasha, who gave its name to the Cerrahpaşa, Fatih district in Istanbul. It has nine faculties, six Institutes, one college, five Vocational schools and ten research centers.

During the past decade, Istanbul University Cerrahpasa Medical School conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Istanbul University Cerrahpasa Medical School" #1 sponsor was "Istanbul University" with 4 trials, followed by "Actelion" with 2 trials sponsored, "Istanbul University - Cerrahpasa (IUC)" with 2 trials sponsored, "Izmir Bakircay University" with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istanbul University Cerrahpasa Medical School" #1 collaborator was "Istanbul University - Cerrahpasa (IUC)" with 4 trials as a collaborator, "AiCuris Anti-infective Cures AG" with 1 trials as a collaborator, "American College of Rheumatology" with 1 trials as a collaborator, "Klinar CRO" with 1 trials as a collaborator and "Tel Aviv University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Istanbul University Cerrahpasa Medical School" are "Pulmonary Arterial Hypertension" (3 trials), "Atrial Fibrillation" (2 trials), "Critical Illness" (2 trials), "Heart Failure" (2 trials) and "Bacterial Resistance" (1 trials). Many other conditions were trialed in "Istanbul University Cerrahpasa Medical School" in a lesser frequency.

Most popular intervention types in "Istanbul University Cerrahpasa Medical School" are "Other" (8 trials), "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evaluation of physical activity level" (2 trials), "Evaluation of quality of life" (2 trials), "Placebo" (2 trials), "Compression Stockings" (1 trials) and "Evaluation of functional exercise capacity" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istanbul University Cerrahpasa Medical School" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Istanbul University Cerrahpasa Medical School". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Istanbul University Cerrahpasa Medical School, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Istanbul University Cerrahpasa Medical School, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".